Amberjack Capital Partners, L.P.: INVX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Amberjack Capital Partners, L.P. on INVX, newest first. How the timeline and the estimate are built.
Amberjack Capital Partners, L.P. held 17,757,322 INVX shares at 2026-09-30 per its 13F-HR filed 2026-11-02.
the latest 13F is the newest step
- period ended2026-09-3013F 17,757,322 sharesChange vs previous 13F -5,000,000 shares
100% of the 13F portfolio, value $479,802,840.
13F-HR 0002026035-26-000011 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2026-06-3013F 22,757,322 sharesChange vs previous 13F 0 shares
100% of the 13F portfolio, value $564,381,586.
13F-HR 0002026035-26-000010 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2026-03-3113F 22,757,322 sharesChange vs previous 13F -6,612,500 shares
100% of the 13F portfolio, value $555,051,084.
13F-HR 0002026035-26-000009 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2025-12-3113F 29,369,822 sharesChange vs previous 13F 0 shares
100% of the 13F portfolio, value $642,318,007.
13F-HR 0002026035-26-000008 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2025-09-3013F 29,369,822 sharesChange vs previous 13F 0 shares
100% of the 13F portfolio, value $544,516,500.
13F-HR 0002026035-26-000007 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2025-06-3013F 29,369,822 sharesChange vs previous 13F 0 shares
100% of the 13F portfolio, value $458,756,620.
13F-HR 0002026035-26-000006 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2025-03-3113F 29,369,822 sharesChange vs previous 13F 0 shares
100% of the 13F portfolio, value $527,482,003.
13F-HR 0002026035-26-000005 filed by Amberjack Capital Partners, L.P.
Accepted , ingested - period ended2024-12-3113F 29,369,822 sharesChange vs previous 13F not available
100% of the 13F portfolio, value $410,296,413.
13F-HR 0002026035-26-000004 filed by Amberjack Capital Partners, L.P.
Accepted , ingested